Abstract:Abstract Introduction Obstructive sleep apnea (OSA) affects more than 10% of older Americans and is associated with future comorbid conditions. The current method for measuring OSA severity, the apnea-hypopnea index (AHI), is poorly correlated to symptom burden and clinical improvement. Hypoxic burden (HB), which quantifies and characterizes OSA-related hypoxemia, has been suggested as an alternative OSA measure. However, more research is needed to understand HB’s predictive ability. Thus, this study investigated whether HB could predict which OSA patients, prescribed CPAP, will have the greatest improvement in measures of sleepiness and cognition. Methods This is a secondary analysis from a trial that investigated the effects of CPAP versus sham treatment on sleepiness [Epworth Sleepiness Scale (ESS), psychomotor vigilance test (PVT)] and cognition [Buschke Selective Reminding Test (BSRT), Sustained Working Memory Test (SWMT), Cogscreen Pathfinder Number (PN)]. Using the SpO2 signal, HB was calculated as the area under the desaturation curve during all desaturation events (sustained >3% dip in SpO2). For categorical analyses, we classified “sleepy” and “not sleepy” in two different ways: ESS≥10 or < 10 and PVT lapses≥4 and < 4, respectively. Results Of the 426 (66% male) participants included, ESS and PVT significantly decreased after two months of treatment; 10.2±4.2 vs 8.0±4.2 (p< 0.001) and 2.5±1.6 vs 2.3±1.4 (p< 0.01), respectively. After correcting for BMI, age, sex, and AHI, baseline HB was associated with a change in sleepiness after treatment (∆ESS R2=0.04, p< 0.001; ∆PVT R2=0.01, p< 0.05). Moreover, having higher baseline HB increased odds for transitioning from “sleepy” to “non-sleepy” based on ESS (1.006 [1.001, 1.012]) or PVT (1.07 [1.003, 1.011]). HB was not associated with change in cognitive variables at follow-up (p>0.05), before correcting for any covariates. Conclusion HB had a significant yet weak effect on subjective (ESS) and objective (PVT) measures of sleepiness after correcting for covariates. HB did not significantly explain changes in any cognitive measure after two months of CPAP treatment. Whether this lack of an association is due to the absence of an overall improvement in cognition or the inability of HB to explain variability remains to be tested. Support (if any) NIH K25HL151912 NIH R01HL171813 NIH R21HL165320

The prognostic capacity of Sleep apnea-specific hypoxic burden on the incidence of cardiovascular events: A comparative study with tradicional polygraphic parameters in patients with Obstructive Sleep Apnea.

Evaluating the clinical value of the hypoxia burden index in patients with obstructive sleep apnea.

0485 Can Hypoxic Burden Predict Improvement in Sleepiness and Cognition in Response to CPAP Treatment in OSA Patients?

Hypoxic indices for obstructive sleep apnoea severity and cardiovascular disease risk prediction: A comparison and application in a community population

Circulating markers of oxidative stress and risk of incident cardiovascular events in obstructive sleep apnea

Time Spent with Saturation below 80% versus 90% in Patients with Obstructive Sleep Apnoea

Synergy of Smoking and Obstructive Sleep Apnea: Cardiovascular Comorbidity and Oxygenation Impact

The use of the sleep apnea-specific hypoxic burden to predict obstructive sleep apnea hypopnea syndrome: Evidence from a large cross-sectional study

Heart Rate Variability as a Surrogate Marker of Severe Chronic Coronary Syndrome in Patients with Obstructive Sleep Apnea

Linear Relationship between Hepatic Steatosis Index and Major Adverse Cardiovascular Events in Hypertensive Patients with Obstructive Sleep Apnea: A Real-World Cohort Study from China

Association between hypoxic burden and common cardiometabolic diseases in patients with severe obstructive sleep apnea

Risk detection in patients with obstructive sleep apnea syndrome based on cardiovascular time series analysis

Phenotypic Characterisation of Obstructive Sleep Apnoea in Acute Coronary Syndrome

Influence of Comorbidity and Obesity on the Occurrence of Vascular Events in Obstructive Apnoea Treated with CPAP

Heterogeneous Effects of Continuous Positive Airway Pressure in Non-Sleepy Obstructive Sleep Apnea on Cardiovascular Disease Outcomes: Post Hoc Machine Learning Analysis of the ISAACC Trial (ECSACT Study)

Effect of OSA on severity and clinical outcomes of patients with Acute Pulmonary Embolism (PE)

The effectiveness of sleep breathing impairment index in assessing obstructive sleep apnea severity.

Sustained oximetric desaturation as a cardiac risk indicator remains correlated with nonspecific sleep apnea indices.

Evaluating the Clinical Value of Oscillatory Cardiopulmonary Coupling in Patients with Obstructive Sleep Apnea Hypopnea Syndrome by Impedance Cardiogram

Impact of obstructive sleep apnea on cardiovascular outcomes in patients treated with percutaneous coronary intervention: rationale and design of the sleep and stent study.

The Impact of Obstructive Sleep Apnea and Comorbidity Status on Cardiovascular Outcomes in Patients with Acute Coronary Syndrome.